NCT07624474 Validation, in a Pediatric Population, of a French Translation of the MEPS/MEPI Score
| NCT ID | NCT07624474 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | MEPI |
| Study Type | INTERVENTIONAL |
| Enrollment | 170 participants |
| Start Date | 2026-04-13 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 170 participants in total. It began in 2026-04-13 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The MEPI (Modified Elbow Performance Index) or MEPS (Modified Elbow Performance Score) is a multidimensional assessment scale for elbow pain and function. This score is widely used in scientific literature, particularly for post-traumatic and post-operative evaluation, including in many French-language studies. However, no French translation of this score has undergone quality criteria verification and validation in a pediatric population.
Eligibility Criteria
Inclusion Criteria: * Pre-test volunteer group: * Patients aged 4 to 17 years followed in the department without an elbow injury * Follow-up schedule compatible with the study protocol * No objection from a parent or legal guardian, with the child's consent if age permits * Test volunteer group: * Patients aged 4 to 17 years followed in the department with a diagnosis of an elbow injury * Follow-up schedule compatible with the study protocol * No objection from a parent or legal guardian, with the child's consent Exclusion Criteria: * Pre-test volunteer group: * Language barrier, lack of understanding of French * Refusal to participate * Confounding factor impairing function * Opposition of parent or legal guardian and/or refusal of child if age permits * Test volunteer group: * Language barrier, lack of understanding of French * Refusal to participate * Confounding factor impairing function * Opposition of parent or legal guardian and/or refusal of child if age permits
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07624474 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 17 Years, studying MEPI. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07624474 currently recruiting?
Yes, NCT07624474 is actively recruiting participants. Contact the research team at klein.celine@chu-amiens.fr for enrollment information.
Where is the NCT07624474 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT07624474 clinical trial?
NCT07624474 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 170 participants.